Key facts
- It has raised $500K; the latest was Early Stage VC in Sep 2025.
- Notable investors include Y Combinator, TRAC VC, Scale Asia Ventures, Dnipro (California).
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Phases
- ·The full record, as it builds
Funding rounds
No funding rounds for Phases are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Phases
Developer of artificial intelligence-based clinical operations tools designed for automating patient recruitment and engagement in clinical trials. The company's platform integrates with existing workflows to scan medical records and conducts human-like voice interviews to assess patient eligibility for clinical trials, enabling research teams to improve enrollment and reduce manual effort.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 3
- Website
- phases.ai/
- Ownership
- Privately Held (backing)
Phases doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Phases shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Phases in its N-PORT filings yet. We sweep new filings monthly.